Literature DB >> 12183235

The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.

Gary Moran1, Derek Sullivan, Joachim Morschhäuser, David Coleman.   

Abstract

The present study investigated the role of the Candida dubliniensis CdCDR1 and CdCDR2 genes in the development of fluconazole resistance. The C. dubliniensis CdCDR1 gene was 92% identical at the nucleotide sequence level to the corresponding C. albicans gene. However, 58% (14 of 24) of C. dubliniensis genotype 1 isolates tested harbored a nonsense mutation in the CdCDR1 open reading frame that converted codon 756 (TAT) to a TAG translational stop codon. Analysis of five of these C. dubliniensis isolates by Western immunoblotting showed that they expressed a truncated 85-kDa CdCdr1p compared to the full-length 170-kDa CdCdr1p. Expression of CdCDR1 alleles from six C. dubliniensis isolates in a pdr5 Saccharomyces cerevisiae strain revealed that CdCDR1 alleles from three isolates that encoded truncated proteins were unable to confer resistance to drugs and antifungals. However, reassignment of the TAG sequence at codon 756 to TAT (encoding tyrosine) in an allele from strain CD36 conferred the ability to mediate resistance to multiple drugs. Fluconazole-resistant isolates of C. dubliniensis harboring functional alleles of CdCDR1 were found to exhibit two- to ninefold-higher levels of CdCDR1 mRNA than did matched fluconazole-susceptible isolates. By comparison, levels of CdMDR1 expression ranged from approximately 50- to 100-fold greater in resistant isolates. Fluconazole resistance was also identified in isolates harboring nonfunctional CdCDR1 alleles, but resistance in these isolates was only associated with increased CdMDR1 expression. Targeted disruption of two functional alleles of CdCDR1 in a fluconazole-resistant derivative of C. dubliniensis that overexpressed both CdCDR1 and CdMDR1 revealed that although CdCDR1 was important for mediating reduced susceptibility to itraconazole and ketoconazole, there was no affect on fluconazole susceptibility in the double mutant. Evidence presented in this study reveals that CdCDR1 is not essential for the development of fluconazole resistance in C. dubliniensis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183235      PMCID: PMC127416          DOI: 10.1128/AAC.46.9.2829-2841.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.

Authors:  M Ruhnke; A Schmidt-Westhausen; J Morschhäuser
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Candida dubliniensis candidaemia in an HIV-positive patient in Ireland.

Authors:  Breida M Boyle; D J Sullivan; C Forkin; F Mulcahy; C T Keane; D C Coleman
Journal:  Int J STD AIDS       Date:  2002-01       Impact factor: 1.359

3.  The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Authors:  D Sanglard; F Ischer; D Calabrese; P A Majcherczyk; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors:  S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Isogenic strain construction and gene targeting in Candida dubliniensis.

Authors:  P Staib; G P Moran; D J Sullivan; D C Coleman; J Morschhäuser
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

6.  Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.

Authors:  S Wirsching; S Michel; J Morschhäuser
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

7.  Differential activation of a Candida albicans virulence gene family during infection.

Authors:  P Staib; M Kretschmar; T Nichterlein; H Hof; J Morschhäuser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  MDR1-mediated drug resistance in Candida dubliniensis.

Authors:  S Wirsching; G P Moran; D J Sullivan; D C Coleman; J Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

Authors:  J F Meis; M Ruhnke; B E De Pauw; F C Odds; W Siegert; P E Verweij
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

10.  Candida dubliniensis fungemia: the first four cases in North America.

Authors:  M E Brandt; L H Harrison; M Pass; A N Sofair; S Huie; R K Li; C J Morrison; D W Warnock; R A Hajjeh
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

View more
  15 in total

1.  Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.

Authors:  Sabrina Schubert; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

Review 2.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

3.  Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Authors:  Asmaa Al Mosaid; Derek J Sullivan; Itzhack Polacheck; Faisal A Shaheen; Osama Soliman; Saleh Al Hedaithy; Sahar Al Thawad; Motaz Kabadaya; David C Coleman
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.

Authors:  Emmanuelle Pinjon; Colin J Jackson; Steven L Kelly; Dominique Sanglard; Gary Moran; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.

Authors:  M Fleischhacker; J Pasligh; G Moran; M Ruhnke
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

6.  Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.

Authors:  Ana Carolina R Souza; Beth Burgwyn Fuchs; Henrique M S Pinhati; Ricardo A Siqueira; Ferry Hagen; Jacques F Meis; Eleftherios Mylonakis; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

7.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

8.  Molecular mechanisms of itraconazole resistance in Candida dubliniensis.

Authors:  Emmanuelle Pinjon; Gary P Moran; Colin J Jackson; Steven L Kelly; Dominique Sanglard; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Candida albicans Zn Cluster Transcription Factors Tac1 and Znc1 Are Activated by Farnesol To Upregulate a Transcriptional Program Including the Multidrug Efflux Pump CDR1.

Authors:  Zhongle Liu; John M Rossi; Lawrence C Myers
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

10.  Genetic differences between avian and human isolates of Candida dubliniensis.

Authors:  Brenda A McManus; Derek J Sullivan; Gary P Moran; Christophe d'Enfert; Marie Elisabeth Bougnoux; Miles A Nunn; David C Coleman
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.